Updated ESMO Clinical Practice Guideline on Renal Cell Carcinoma – ESMO

ESMO – European Society for Medical Oncology posted on LinkedIn:

“Updated Renal Cell Carcinoma:

ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Assessing mature data for first-line metastatic trials as well as sequencing strategies, and new agents such as belzutifan.

Algorithms for the management of localised and advanced or metastatic disease are also provided.”

Additional information.
Source: ESMO/LinkedIn